Hunter C. Smith
2017
In 2017, Hunter C. Smith earned a total compensation of $1.1M as Chief Financial Officer at RHYTHM PHARMACEUTICALS.
Compensation breakdown
| Non-Equity Incentive Plan | $70,490 |
|---|---|
| Option Awards | $832,497 |
| Salary | $159,795 |
| Other | $27,495 |
| Total | $1,090,277 |
Smith received $832.5K in option awards, accounting for 76% of the total pay in 2017.
Smith also received $70.5K in non-equity incentive plan, $159.8K in salary and $27.5K in other compensation.
Rankings
In 2017, Hunter C. Smith's compensation ranked 8,575th out of 14,666 executives tracked by ExecPay. In other words, Smith earned more than 41.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,575 out of 14,666 | 42nd |
Division Manufacturing | 3,257 out of 5,772 | 44th |
Major group Chemicals And Allied Products | 1,088 out of 2,075 | 48th |
Industry group Drugs | 862 out of 1,731 | 50th |
Industry Pharmaceutical Preparations | 673 out of 1,333 | 50th |
Source: SEC filing on April 30, 2018.
Smith's colleagues
We found two more compensation records of executives who worked with Hunter C. Smith at RHYTHM PHARMACEUTICALS in 2017.